| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8210883 | International Journal of Radiation Oncology*Biology*Physics | 2018 | 49 Pages |
Abstract
Ablative HFRT at â¥10 Gy per fraction enhances killing of NSCLC with high RIP3 expression via preferential stimulation of necroptosis. RIP3 may serve as a useful biomarker to predict favorable response to stereotactic body radiation therapy.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Huan-Huan MD, PhD, Zhi-Qiang PhD, Dong MD, PhD, Nicholas G. MD, Ming-Han MD, Jing-Jing MD, PhD, Chao MD, Juan MD, Xian-Liang MD, Chun-Lei MD, Li-Jun MD, Guo-Guang PhD, Mao-Bin MD, PhD, Xi-Shan MD, PhD, Zhi-Yong MD, PhD,